IRadimed Corporation

NASDAQ: IRMD · Real-Time Price · USD
70.32
0.17 (0.24%)
At close: Aug 15, 2025, 9:55 AM

IRadimed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
73.24M 65.56M 53.3M 41.81M
Cost of Revenue
16.89M 15.4M 12.02M 9.76M
Gross Profit
56.35M 50.16M 41.28M 32.05M
Operating Income
21.96M 20.04M 15.63M 9.82M
Interest Income
2.19M 1.86M 581.85K 34.81K
Pretax Income
24.28M 21.74M 16.18M 9.84M
Net Income
19.23M 17.19M 12.83M 9.33M
Selling & General & Admin
31.55M 27.26M 23.38M 20.33M
Research & Development
2.83M 2.86M 2.28M 1.91M
Other Expenses
n/a n/a n/a 18.61K
Operating Expenses
34.39M 30.12M 25.65M 22.23M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
15.62M 12.14M 12.68M 10.56M
Cost & Expenses
51.28M 45.53M 37.68M 32M
Income Tax Expense
5.04M 4.55M 3.35M 510.82K
Shares Outstanding (Basic)
12.67M 12.6M 12.56M 12.35M
Shares Outstanding (Diluted)
12.78M 12.72M 12.64M 12.59M
EPS (Basic)
1.52 1.36 1.02 0.76
EPS (Diluted)
1.50 1.35 1.02 0.74
EBITDA
22.78M 20.8M 16.3M 11.22M
EBIT
21.96M 20.04M 15.63M 9.84M
Depreciation & Amortization
817.66K 765.18K 670.67K 634.01K